Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.
Author(s) -
Paolo Spirito,
Claudio Rapezzi,
Camillo Autore,
Paolo Bruzzi,
Pietro Bellone,
Paolo Ortolani,
Pietro Vincenzo Fragola,
F Chiarella,
Massimo Zoni-Berisso,
Angelo Branzi
Publication year - 1994
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.90.6.2743
Subject(s) - medicine , hypertrophic cardiomyopathy , asymptomatic , cardiology , ventricular tachycardia , sudden death , ambulatory , cardiomyopathy , population , heart failure , sudden cardiac death , environmental health
In the early 1980s, studies performed in highly selected referral patients with hypertrophic cardiomyopathy reported a strong association between the presence of brief episodes of ventricular tachycardia (VT) on ambulatory ECG monitoring and sudden death. These observations led to antiarrhythmic treatment in many patients with hypertrophic cardiomyopathy and brief episodes of VT. In recent years, however, a growing awareness of the potential arrhythmogenic effects of antiarrhythmic medications has raised doubts regarding such a therapeutic approach, particularly in less selected and lower-risk patient populations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom